ExpertFORUM Regulatory Affairs - Towards a faster and more tailored marketing authorisation in Europe and in the US?
- The EU and the US market: parallel or sequential marketing authorisations?
- The Future: breakthrough versus adaptive licensing
- The Present: accelerated/cond. approval, abridged procedures
- Marketing authorisation versus HTA/market access conditions
Are you involved in your company's regulatory strategy? Then you won't want to miss out on this opportunity for a thorough discussion with three outstanding regulatory affairs experts.
This ExpertFORUM focuses on the current challenges when registering new products in Europe and the US.
- How does the marketing authorisation system (including the new option of adaptive licensing) fit with the HTA requirements?
- Are there shortcuts when pursuing an approval in the EU and the US?
- What about orphan drugs in these systems?
Here you'll get first-hand answers and valuable tips for your regulatory strategy
Termin
Datum: | 05.03.2015 |
Ort: | NH Frankfurt City Vilbeler Straße 2 -60313 Frankfurt |
Preis: | 990,00 EUR zzgl. MwSt. |
Zielgruppe
This ExpertFORUM addresses the needs of regulatory affairs professionals in the pharmaceutical industry. Especially those who are involved in the regulatory strategy (EU and/or the US) will benefit from the round table.
Kontaktinformationen
Weitere Pharma-Seminare, die Sie interessieren könnten:
13.11.2024 | Lean Management im Labor (1 Tag) |
28.11.2024 | Lean Lab – Erfolgreiche Optimierungen im Labor |
26.09.2024 | Lean Lab – Erfolgreiche Optimierungen im Labor |
17.04.2024 | Lean Management im Labor (1 Tag) |
10.10.2024 | Laborplanung mit Lean Lab Design - Webinar |